Drug Development Core

Overview

The Drug Development Core brings together the expertise of Roswell Park Cancer Institute and the UB School of Pharmacy and Pharmaceutical Sciences to provide a resource (including training) in preclinical and early clinical development of novel compounds for investigators.

We provide a centralized resource for preclinical pharmacology, pharmacokinetic-pharmacodynamics and early phase clinical trial design, conduct and management.

Directors

Gene D. Morse, PharmD
Director

  • SUNY Distinguished Professor of Pharmacy Practice
  • Director, Translational Pharmacology Research Core
  • UB School of Pharmacy and Pharmaceutical Sciences
  • Center of Excellence in Bioinformatics and Life Science
  • Director, UB Center for Integrated Global Biomedical Sciences

Igor Puzanov, MD, MSCI, FACP
Associate Director

  • Director, Early Phase Clinical Trials Program
  • Chief of Melanoma
  • Co-Leader, CCSG Experimental Therapeutics Program
  • Professor of Oncology, Department of Medicine
  • Roswell Park Cancer Institute